Piflufolastat F-18 injection drugs (Pylarify) from Lantheus (Notice of Intent to sole source)
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH - CC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation NOI-27-000004 in this department, oldest first.
- Sep 22, 2026 · this noticePre-solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Match: Same agency (National Institutes of Health), same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SRI INTERNATIONAL Menlo Park CA 94025 USA | 2 | – + 2 shared | Jul 8, 2026 |
| CURIA GLOBAL INC | 1 | – + 1 shared | May 5, 2026 |
| EMINENT SERVICES CORP | 1 | – + 1 shared | Jul 8, 2026 |
| ALCHEM LABORATORIES CORPORATION | 1 | – + 1 shared | May 5, 2026 |
| MRIGLOBAL Kansas City MO 64110 USA | 1 | – + 1 shared | May 5, 2026 |
| MURTY PHARMACEUTICALS, INC. | 1 | – + 1 shared | Jul 8, 2026 |
| KYMANOX CORP | 1 | – + 1 shared | Jul 8, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Jul 8, 2026KYMANOX CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026SRI INTERNATIONAL Menlo Park CA 94025 USA$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026MURTY PHARMACEUTICALS, INC.$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026EMINENT SERVICES CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- May 5, 2026SRI INTERNATIONAL Menlo Park CA 94025 USA$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- May 5, 2026CURIA GLOBAL INC$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- May 5, 2026MRIGLOBAL Kansas City MO 64110 USA$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- May 5, 2026ALCHEM LABORATORIES CORPORATION$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
Competitive landscape
For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.